Visual China Group (000681.SZ) subsidiary terminates joint investment with professional investment institutions.
Visual China Group (000681.SZ) has issued an announcement. Prior to this, the company's wholly-owned subsidiary, Beijing Huaxia Visual Technology Group, has...
Visual China Group (000681.SZ) announced that its wholly-owned subsidiary, Beijing Huaxia Vision Technology Group Co., Ltd. ("Huaxia Vision"), planned to invest 30 million yuan with its own funds in partnership with Hainan Zhiqiao Private Equity Fund Management Partnership Enterprise (Limited Partnership) ("Hainan Zhiqiao") in Yancheng Zhihua Entrepreneurship Investment Fund Partnership Enterprise (Limited Partnership) ("Yancheng Zhihua"), and serve as a limited partner.
The decision to terminate the investment was made after a comprehensive consideration of the deep compatibility with the company's current and future overall development strategy and the optimization of resource allocation. After careful study and discussion by the company's management, and full and friendly negotiations with relevant parties, the company decided to terminate the investment.
Related Articles

New Stock News | OmniVision Integrated Circuits Group, Inc. (603501.SH) plans to IPO in Hong Kong. The China Securities Regulatory Commission requires an explanation for reasons of inconsistency in the identification of the controlling shareholder in the filing materials.

China Yuchai International Limited (CYD.US) reports strong revenue and profit growth in the first half of the year, with pre-market trading up nearly 9%.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The employee stock ownership plan plans to reduce its shareholding by no more than 3%.
New Stock News | OmniVision Integrated Circuits Group, Inc. (603501.SH) plans to IPO in Hong Kong. The China Securities Regulatory Commission requires an explanation for reasons of inconsistency in the identification of the controlling shareholder in the filing materials.

China Yuchai International Limited (CYD.US) reports strong revenue and profit growth in the first half of the year, with pre-market trading up nearly 9%.

Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SH): The employee stock ownership plan plans to reduce its shareholding by no more than 3%.

RECOMMEND

Seven Ministries Issue Comprehensive Roadmap for Brain-Computer Interface Industry Advances
08/08/2025

GPT-5 Makes a Late-Night Debut as Microsoft Leads Integration; Institutions Optimistic About Accelerated AI Programming Development
08/08/2025

Federal Reserve: U.S. Consumer Inflation Expectations Rose in July, Labor Market Sentiment Improved
08/08/2025